News
1d
MedPage Today on MSNEnd of Compounded Semaglutide; 464M Teens Will Have Obesity; GLP-1 Scripts SkyrocketResearchers said a single daytime sample of serum 17-hydroxyprogesterone and/or androstenedione is sufficient to monitor ...
In response to a proposal submitted by Intas Pharmaceuticals, the Subject Expert Committee (SEC) under the Central Drugs ...
Among patients who experienced an early cardiovascular event, those treated with semaglutide had approximately 40% fewer ...
An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...
Glenmark Pharmaceuticals seeks licensing deal for ISB 2001 drug candidate, plans growth with semaglutide in India.
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.
1d
News-Medical.Net on MSNResearchers identify key nerve cells behind semaglutide's appetite reductionA specific group of nerve cells in the brain stem appears to control how semaglutide affects appetite and weight – without ...
Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...
Veru's pivot with enobosarm: groundbreaking Phase 2b results enhance GLP-1 therapy outcomes. A positive launch could yield ...
1️⃣ ‘Summer of hell’: What’s typically a key money-making time for airlines could fall short this year. Fears about flying, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results